MARKET

UTHR

UTHR

United Therapeutics Corp.
NASDAQ
542.66
-0.73
-0.13%
Pre Market: 542.65 -0.01 0.00% 04:00 06/29 EDT
OPEN
544.37
PREV CLOSE
543.39
HIGH
554.52
LOW
535.44
VOLUME
3
TURNOVER
0
52 WEEK HIGH
609.35
52 WEEK LOW
272.12
MARKET CAP
23.03B
P/E (TTM)
20.03
1D
5D
1M
3M
1Y
5Y
1D
United Therapeutics Chairperson, CEO Martine Rothblatt reports sale of 9,500 shares worth $5.22 million
PUBT · 2d ago
United Therapeutics (UTHR) Could Be 17% Below Fair Value As First Quarter Miss Shakes Confidence
Simply Wall St · 4d ago
United Therapeutics Chairperson and CEO Martine Rothblatt disposes of common shares worth $5.08 million
PUBT · 4d ago
Tyvaso IPF Trial Win Amid Revenue Miss Could Be A Game Changer For United Therapeutics (UTHR)
Simply Wall St · 5d ago
United Therapeutics CFO James Edgemond sells 8,750 shares worth $4.7 million
PUBT · 5d ago
United Therapeutics CEO Martine Rothblatt disposes of 11,480 common shares worth $6.19 million
PUBT · 6d ago
Weekly Report: what happened at UTHR last week (0615-0619)?
Weekly Report · 06/22 09:29
United Therapeutics Chairperson, CEO Martine Rothblatt sells $4.9 million in common shares
PUBT · 06/15 20:36
More
About UTHR
United Therapeutics Corporation is a pharmaceutical company. The Company markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection for the treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin. Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder product.

Webull offers United Therapeutics Corp stock information, including NASDAQ: UTHR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UTHR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading UTHR stock methods without spending real money on the virtual paper trading platform.